Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101121-2 Candida albicans+tropicalis DNA PrThr Bld Pt Ord Probe.amp.tar &nbsp; ACTIVE Candida albicans and tropicalis DNA [Presence] in Blood by NAA with probe detection &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 101121-2 &nbsp; Probe.amp.tar &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 C albicans+tropicalis DNA Bld Ql NAA probe &nbsp; &nbsp; &nbsp; N &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C albicans; C albicans + tropicalis DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; WB; Whole blood 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101122-0 Mephobarbital MCnc Bld Pt Qn Confirm &nbsp; ACTIVE Mephobarbital [Mass/volume] in Blood by Confirmatory method &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mcg/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 101122-0 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Mephobarbital Bld Cfm-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Barbiturate; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Mebaral; Methylphenobarbital; Phenitone; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; 0
101123-8 Bacterial carbapenem resistance blaIMI gene PrThr Isolate/Specimen Pt Ord Molgen &nbsp; ACTIVE Bacterial carbapenem resistance blaIMI gene [Presence] by Molecular method &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 101123-8 &nbsp; Molgen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 blaIMI Islt/Spm Ql &nbsp; &nbsp; &nbsp; N &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101124-6 Bacterial carbapenem resistance blaIMI+blaNMC genes PrThr Isolate/Specimen Pt Ord Molgen &nbsp; ACTIVE Bacterial carbapenem resistance blaIMI+blaNMC genes [Presence] by Molecular method &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 101124-6 &nbsp; Molgen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 blaIMI+blaNMC genes Islt/Spm Ql &nbsp; &nbsp; &nbsp; N &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101125-3 Bacterial carbapenem resistance blaOXA-235-like gene PrThr Isolate/Specimen Pt Ord Molgen &nbsp; ACTIVE Bacterial carbapenem resistance blaOXA-235-like gene [Presence] by Molecular method &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 101125-3 &nbsp; Molgen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 blaOXA-235-like gene Islt/Spm Ql &nbsp; &nbsp; &nbsp; N &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101126-1 Bacterial carbapenem resistance blaOXA-24+blaOXA-40 gene PrThr Isolate/Specimen Pt Ord Molgen &nbsp; ACTIVE Bacterial carbapenem resistance blaOXA-24+blaOXA-40 gene [Presence] by Molecular method &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 101126-1 &nbsp; Molgen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 blaOXA-24+blaOXA-40 Islt/Spm Ql &nbsp; &nbsp; &nbsp; N &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.78 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101127-9 Bacterial carbapenem resistance blaSIM gene PrThr Isolate/Specimen Pt Ord Molgen &nbsp; ACTIVE Bacterial carbapenem resistance blaSIM gene [Presence] by Molecular method &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 101127-9 &nbsp; Molgen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 blaSIM Islt/Spm Ql &nbsp; &nbsp; &nbsp; N &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101128-7 Theoretical limit of detection Num XXX Pt Qn Calculated &nbsp; ACTIVE Theoretical limit of detection [#] in Specimen by calculation &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MISC &nbsp; 101128-7 &nbsp; Calculated &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Theoretical limit of detection Spec Calc &nbsp; &nbsp; &nbsp; N &nbsp; Calc; Calculation; Cnt; Count; Misc; Miscellaneous; Number; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
101129-5 Assay Sensitivity Num Laboratory device Pt Qn &nbsp; &nbsp; ACTIVE Laboratory device Assay Sensitivity &nbsp; ADD DefinitionDescription &nbsp; &nbsp; # &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DEVICES &nbsp; 101129-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Lab Device &nbsp; &nbsp; &nbsp; N &nbsp; Cnt; Count; Lab Device; Number; Point in time; QNT; Quan; Quant; Quantitative; Random 2.74 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
10113-9 ST wave displacement.end.lead V2 Elpot Heart Pt Qn EKG &nbsp; ACTIVE ST wave end displacement in lead V2 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10113-9 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ST wave ED L-V2 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave ED L-V2; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
101130-3 Mast cells/Cells NFr Bone mar Pt Qn Flow cytometry &nbsp; ACTIVE Mast cells/cells in Bone marrow by Flow cytometry (FC) &nbsp; NAM DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 101130-3 &nbsp; Flow cytometry &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Masts NFr Mar FC &nbsp; &nbsp; &nbsp; N &nbsp; BM; BON; Bone marrow; Cell; Cellularity; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); Masts; minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random 2.79 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
101131-1 B-cell precursors NFr Bone mar Pt Qn Flow cytometry &nbsp; ACTIVE B-cell precursors in Bone marrow by Flow cytometry (FC) &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 101131-1 &nbsp; Flow cytometry &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 B-cell precursors NFr Mar FC &nbsp; &nbsp; &nbsp; N &nbsp; B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BM; BON; Bone marrow; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random 2.81 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Release 2.81: SYSTEM: Adjusted system part to Bone mar from Bone marrow; 0
101132-9 Glucose post XXX challenge panel - Ser/Plas Pt - &nbsp; &nbsp; ACTIVE Glucose post XXX challenge panel - Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CHAL &nbsp; 101132-9 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Glucose post XXX challenge pnl SerPl &nbsp; &nbsp; &nbsp; N &nbsp; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.74 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101133-7 Organ &or tissue donation consent Find {Setting} Pt Doc Patient &nbsp; TRIAL Organ AndOr tissue donation consent Document &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 101133-7 &nbsp; Patient &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Organ AndOr tissue donation consent &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Finding; Findings; Form; Point in time; Random 2.74 2.74 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101134-5 Appointment reminder Find {Setting} Pt Doc {Role} &nbsp; TRIAL Appointment reminder &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 101134-5 &nbsp; {Role} &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Appointment reminder &nbsp; &nbsp; &nbsp; N &nbsp; DOC.ONT; Document; Finding; Findings; Point in time; Random 2.77 2.74 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101135-2 Discharge Summary Note Find Ambulance Pt Doc {Role} &nbsp; TRIAL Ambulance Discharge summary &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 101135-2 &nbsp; {Role} &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Ambulance D/C sum &nbsp; &nbsp; &nbsp; N &nbsp; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note 2.74 2.74 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101136-0 End of treatment letter Find {Setting} Pt Doc Radiation oncology &nbsp; TRIAL Radiation oncology End of treatment letter &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.ONTOLOGY &nbsp; 101136-0 &nbsp; Radiation oncology &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Radiation Onc End of treatment letter &nbsp; &nbsp; &nbsp; N &nbsp; Cancer; DOC.ONT; Document; Finding; Findings; Point in time; Random; Tx 2.74 2.74 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101137-8 MNS29 PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE MNS29 [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 101137-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 MNS29 SerPl Ql &nbsp; &nbsp; &nbsp; N &nbsp; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101138-6 ER super little a Ab PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE ER^a Ab [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 101138-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ER^a Ab SerPl Ql &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; ER^a; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101139-4 H little ro Ab PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE Hro Ab [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 101139-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Hro Ab SerPl Ql &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Hro; Hro Ab; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
10114-7 ST wave displacement.end.lead V3 Elpot Heart Pt Qn EKG &nbsp; ACTIVE ST wave end displacement in lead V3 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 10114-7 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ST wave ED L-V3 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave ED L-V3; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
101140-2 Salmonella sp Ag PrThr Stool Pt Ord IA.rapid &nbsp; ACTIVE Salmonella sp Ag [Presence] in Stool by Rapid immunoassay &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 101140-2 &nbsp; IA.rapid &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Salmonella Ag Stl Ql IA.rapid &nbsp; &nbsp; &nbsp; N &nbsp; Antigen; Antigens; Bowel movement; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; IAA; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Salmonel; Screen; species; spp; Stl; Stool = Fecal; SUDS 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101141-0 NAT2 gene targeted mutation analysis Find Bld/Tiss Pt Doc Molgen &nbsp; ACTIVE NAT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MOLPATH.PHARMG &nbsp; 101141-0 &nbsp; Molgen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 NAT2 Mut Anl Bld/T &nbsp; &nbsp; &nbsp; N &nbsp; Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; N-Acetyltransferase 2; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101142-8 NAT2 gene allele Geno Bld/Tiss Pt Nom Molgen &nbsp; ACTIVE NAT2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MOLPATH.PHARMG &nbsp; 101142-8 &nbsp; Molgen &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 NAT2 gene allele Geno Bld/T &nbsp; &nbsp; &nbsp; N &nbsp; Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
101143-6 NAT2 gene product metabolic activity interpretation Imp Bld/Tiss Pt Ord Molgen &nbsp; ACTIVE NAT2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MOLPATH.PHARMG &nbsp; 101143-6 &nbsp; Molgen &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 NAT2 gene prod met activ imp Bld/T-Imp &nbsp; &nbsp; &nbsp; N &nbsp; Activ; Actvty; Blood; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; NAT2 gene prod met activ imp; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.75 2.74 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
108,248 results found